Science and Research

Upper-Airway Microbiome, Mucociliary Function, and Clinical Outcomes in Bronchiectasis: Data from the EMBARC-BRIDGE Study

Rationale: Infection is a key disease driver in bronchiectasis, and the upper-airway microbiome has been known to shape the lower-airway microbiome. Objective: To evaluate the relationship between the upper-airway microbiome, mucociliary function, and clinical outcomes in bronchiectasis. Methods: Nasopharyngeal swabs were collected from 344 patients with bronchiectasis enrolled across five European centers. A total of 104 patients had nasopharyngeal samples obtained at the 1-year follow-up. Microbiome composition was assessed according to Bronchiectasis Severity Index and severe exacerbations. The

  • Choi, H.
  • Richardson, H.
  • Hennayake, C.
  • Shuttleworth, M.
  • Cant, E.
  • Bottier, M.
  • Spinou, A.
  • Robertson, K.
  • Long, M. B.
  • De Soyza, A.
  • Ringshausen, F. C.
  • Goeminne, P.
  • Lorent, N.
  • Haworth, C.
  • Altenburg, J.
  • Loebinger, M. R.
  • Alferes de Lima Headley, D.
  • Dicker, A. J.
  • Blasi, F.
  • Shteinberg, M.
  • Aliberti, S.
  • Polverino, E.
  • Sibila, O.
  • Shoemark, A.
  • Chalmers, J. D.

Keywords

  • Humans
  • *Bronchiectasis/microbiology/physiopathology
  • Female
  • Male
  • Middle Aged
  • *Microbiota
  • Aged
  • *Mucociliary Clearance/physiology
  • Severity of Illness Index
  • *Nasopharynx/microbiology
  • Dysbiosis/microbiology
  • bronchiectasis
  • dysbiosis
  • infection
  • microbiome
  • precision medicine
Publication details
DOI: 10.1164/rccm.202504-0875OC
Journal: Am J Respir Crit Care Med
Pages: 2296-2306 
Number: 12
Work Type: Original
Location: BREATH
Disease Area: CFBE
Partner / Member: MHH
Access-Number: 40938736


chevron-down